Moleculin Biotech Stock Coverage and Analysis at StockNews
Moleculin Biotech's stock has been given a "sell" rating by a firm, with a 1-year low of $4.34 and a ...
- Latest
- Trending
Moleculin Biotech's stock has been given a "sell" rating by a firm, with a 1-year low of $4.34 and a ...
U.S. WTI crude futures for May delivery rise 0.5% to $81.79 a barrel. Both benchmarks on track for third month ...
Florida bill may give the state regulatory control over food delivery apps like Uber and GrubHub. Florida Restaurant and Lodging ...
Losses are expected to increase by 32% to CN¥3.15 per share for Sichuan Kelun-Biotech Biopharmaceutical. This is a significant change ...
US District Judge Vince Chhabria dismissed an antitrust lawsuit against Apple. While restrictions on iOS were alleged, the court found ...
LG plans to invest $74.3 billion in South Korea through 2028, focusing on AI, biotechnology, batteries, clean tech, and displays. ...
Traders work on the NYSE floor, as Terry shares financial insights and answers questions. Latest news, business updates, and comprehensive ...
Trading on margin increases financial risks; Fusion Media cautions data may not be real-time or accurate; intellectual property rights are ...
The first version of the new Instacart API went live on March 27, allowing retailers like Costco and Hy-Vee to ...
The incident on the bridge led to temporary disruptions in coal exports, impacting stock market trends for coal companies and ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.